Table 4.
Nonserious adverse events reported by at least one study subject during trial.
Placebo (n=46) | 1.25 g/d n-3 (n=46) | 2.5 g/d n-3 (n=46) | p-value | |
---|---|---|---|---|
Ear ache | 6 (13%) | 4 (9%) | 2 (4%) | 0.39 |
Sore throat | 3 (7%) | 10 (22%) | 8 (17%) | 0.10 |
Swollen glands | 1 (2%) | 0 (0%) | 1 (2%) | 1.00 |
Stuffy nose | 18 (39%) | 20 (43%) | 23 (50%) | 0.60 |
Wheeze | 3 (7%) | 1 (2%) | 2 (4%) | 0.87 |
Dry cough | 10 (22%) | 10 (22%) | 6 (13%) | 0.50 |
Wet cough | 8 (17%) | 6 (13%) | 6 (13%) | 0.87 |
Nausea | 7 (15%) | 6 (7%) | 8 (17%) | 0.28 |
Stomach pain | 12 (26%) | 13 (28%) | 14 (30%) | 0.97 |
Diarrhea | 10 (22%) | 7 (15%) | 12 (26%) | 0.48 |
Other symptoms | 25 (54%) | 25 (54%) | 23 (50%) | 0.93 |
Data are n (%).